In Brief: Circulatory System Devices Panel
This article was originally published in The Gray Sheet
Executive Summary
Circulatory System Devices Panel: FDA's first product development protocol scheduled for closed-door panel review Dec. 4, 9 a.m. to 5 p.m., at a meeting in Rockville, Maryland. The meeting is closed to the public because the panel will be discussing confidential information. A public forum will be held prior to closed panel discussion between 8 a.m. and 9 a.m. For more information, call John Stuhlmuller at 301/443-8243, ext. 152...